# XSpray Pharma – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/xspray-pharma
Company JSON: https://spela.port0.org/company/xspray-pharma/company.json
Documents JSON: https://spela.port0.org/company/xspray-pharma/documents.json
Updated: 2026-08-07T08:48:03Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/xspray-pharma/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/xspray-pharma/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/xspray-pharma/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/xspray-pharma/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/xspray-pharma/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/xspray-pharma/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/xspray-pharma/reports
- JSON: https://spela.port0.org/company/xspray-pharma/reports/reports.json
- 2026 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2026: https://view.news.eu.nasdaq.com/view?id=bb97dea85ddf5e0ff88f534513012a6ab&lang=sv&src=listed
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b6b31ffd7db671f2853e808cbe9a72b56&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=bbbb21defe00d4e64bb9bb66ddaf18d7d&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b210eed9d93a4d30bfee43bb21d2dfa36&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b7f3d8999af9843718ca8f465017f4459&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b0d221895a433d699d9e51fac6f6ec0ad&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b84be54ffb099e395070137f85e4f50fd&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b90ee4f2d0d123f6356c6cbf26c0e28d8&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=bbe94d8780b1a190c213beec15aad7e2e&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=bbe17d0868d4a7dd5c97b7cea4ed2b6d0&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=bee040ef17a0ba896880fbca03f7fab90&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=bf6047f3a3d8dda0ea3f215bbc18f12c6&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=ba29714bc618f03e7f4c72f0ac1adc1bf&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=bd16eef133f40bb919111be18d697058d&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b0e99301c43a160e104a2d8e31cc05d7a&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b65b2da9c0cea0909d3fcf2e0af50fd5c&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b915d08ed3d340c5c2238ff2e30b5184c&lang=sv&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/xspray-pharma/finansinspektionen
- Summary: https://spela.port0.org/company/xspray-pharma/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/xspray-pharma/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/xspray-pharma/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/xspray-pharma/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/xspray-pharma/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q2 2026: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/xspray-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/xspray-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt